Vakiener Victoria
Insider CIK 1826263 · CMRX Director · EPZM Chief Commercial Officer · ARWR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-19 | 2025-12-23 | 5,281 | $67.97 | $358.9K | 37,683 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-19 | 2025-12-23 | 1,960 | $68.39 | $134.0K | 35,723 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-19 | 2025-12-23 | 2,799 | $66.63 | $186.5K | 42,964 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 45,763 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 50,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 60,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 60,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 35,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 60,000 | — | $0 | 0 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2024-12-18 | 2024-12-20 | 16,733 | $22.99 | $384.7K | 37,944 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-12-16 | 2024-12-18 | 8,994 | $21.91 | $197.1K | 21,211 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2024-06-20 | 2024-06-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-05-02 | 2024-05-06 | 1,799 | $23.31 | $41.9K | 30,205 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-11 | 2024-01-16 | 1,100 | $38.84 | $42.7K | 32,001 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-11 | 2024-01-16 | 3,620 | $37.87 | $137.1K | 33,101 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2023-12-15 | 2023-12-19 | 14,987 | $25.41 | $380.8K | 36,721 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-09-28 | 2023-10-02 | 1,550 | $26.33 | $40.8K | 21,734 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2023-06-09 | 2023-06-12 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award deriv | 2023-01-10 | 2023-01-11 | 4,593 | — | $0 | 4,593 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | D To issuer | 2023-01-10 | 2023-01-11 | 1,764 | — | $0 | 15,417 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2023-01-10 | 2023-01-11 | 7,867 | — | $0 | 23,284 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2022-06-23 | 2022-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2021-06-23 | 2021-06-25 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2021-04-22 | 2021-04-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2021-02-04 | 2021-02-05 | 817 | $11.21 | $9.2K | 52,685 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2021-02-01 | 2021-02-02 | 121,754 | — | $0 | 121,754 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-02-01 | 2021-02-02 | 25,520 | — | $0 | 53,502 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2021-01-25 | 2021-01-27 | 599 | $11.41 | $6.8K | 27,982 | SEC↗ |